With a large aging population and rising costs, healthcare spending is likely to have negative implications across the economy, according to a recent report from Moody’s.

Healthcare spending has risen rapidly over the last decade, jumping 44 percent per person across all major healthcare categories, according to a new study by the Health Care Cost Institute.

Healthcare costs continue to balloon in the United States, and secret contracts between hospital systems and insurers may be playing a big role in keeping those costs up.

The Senate approved a major bill to tackle the opioid crisis with a nearly unanimous vote.

The Coca-Cola Company admitted it is taking a hard look at the use of cannabis in drinks after reports emerged that the company was in talks to develop a health drink infused with cannabidiol, a compound from the cannabis plant.

CVS Health will allow self-funded insurers to exclude some drugs from coverage if the cost is too high. The policy has been met with criticism from the pharmaceutical industry, which argues CVS is dividing treatment at arbitrary values.

CVS Health’s $69 billion takeover of Aetna may soon be greenlit by the U.S. Department of Justice Antitrust Division, according to Reuters, which cited a source familiar with the matter.

On Monday, Sept. 17, Indianapolis-based TriMedx announced plans to buy the healthcare technologies division of Aramark Corporation for $300 million. The two companies have signed a definitive agreement and expect the transaction to be completed by the end of the year.